YK-11 - Magnus

YK-11 Magnus Pharmaceuticals SARMS Information:

YK-11 Magnus Pharmaceuticals SARMS is a novel oral SARM, a selective androgen receptor modulator, which acts as a myostatin inhibitor in parallel with its effect as SARM. YK-11 Magnus Pharmaceuticals SARMS has tremendously high bioavailability and it has also been shown that YK-11 Magnus Pharmaceuticals SARMS binds very selectively to the androgen receptors of the muscle tissue. Although a great deal of research is still necessary with this substance, it is apparent that YK-11 SARMS acts more anabolically than testosterone without the steroid-like side effects. The inhibition of the protein myostatin (GDF-8) triggered by YK-11 Magnus Pharmaceuticals SARMS likewise contributes to the fact that the anabolic potential of this substance is significantly higher than in the SARMs available to date.

YK-11 Magnus Pharmaceuticals SARMS Effect:

So far, it has been shown that the effect of YK-11 Magnus Pharmaceuticals SARMS is to be much stronger than that of LGD-4033. It was found that YK-11 Magnus Pharmaceuticals SARMS has stronger anabolic properties and lower androgenic side effects with the same dosage compared to LGD-4033. In addition, under the influence of YK-11 Magnus Pharmaceuticals SARMS, the muscle cell cultures produced significantly more anabolic growth factors than under the influence of DHT (see DHT inhibitor), ie dihydrotestosterone, which is the most bioactive form of testosterone. YK-11 Magnus Pharmaceuticals SARMS allows the muscles to have the general effect as SARM, which has a much greater growth potential due to the greatly increased production of follistatin, the counterpart of myostatin. YK-11 Magnus Pharmaceuticals SARMS apparently causes muscle cells to produce significantly more follistatin than they do under the influence of DHT. The protein myostatin, just opposite to the follistatin, ensures that the muscle composition is not limited in simplified terms. By inhibiting myostatin, the muscle build-up is much more extensive and faster than would normally be the case.

YK-11 Magnus Pharmaceuticals SARMS Dosage:

At the dosages so far speaks of 2-10mg YK-11 Magnus Pharmaceuticals SARMS divided on 1-2 gifts a day for ideal results. This low dosage, in turn, indicates the strong potential of this SARM. The medication should not exceed 6-8 weeks. Although little is known about the suppression of body-borne testosterone production, a so-called PCT, ie post-cycle therapy, should be performed for safety reasons. In addition, the intake of zinc while taking YK-11 Magnus Pharmaceuticals SARMS is recommended as a natural aromatase inhibitor.

YK-11 Magnus Pharmaceuticals SARMS Possible side effects:

Although the YK-11 Magnus Pharmaceuticals SARMS have not yet been shown to have any real side effects, a suppressive effect on the body‘s testosterone balance is likely. Steroid-type side effects are largely excluded.

This article is not intended for advice or advice regarding the subject matter, nor for the purpose of the application, but merely for the purpose of clarification on this topic.